How are insurers likely to treat Dendreon’s

Johnson & Johnson ( NYSE: JNJ ) has started posting information on its payments to doctors, joining the Big Pharma movement toward disclosure. But J&J’s reports aren’t as forthcoming as those from rivals such as Merck and Pfizer . They identify individual doctors and payments made, but they

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that data from the ATHENA (Addressing THE Need for Advanced HPV Diagnostics) U.S. registration trial of over 47,000 women demonstrate that two human papillomavirus genotypes, HPV 16 and HPV 18, can identify those women with cervical pre-cancer missed by cytologic examination with a…

Johnson & Johnson’s ( NYSE:

There have been

Alcon’s ( NYSE: ACL ) independent directors are upping the ante in their squabble with Novartis . The directors committee (IDC) has now set up a $50 million litigation trust to make sure that minority shareholders

We’ve been waiting for specifics on Merck’s

Eli Lilly and Company (NYSE: LLY) and Alnara Pharmaceuticals, Inc. have signed a definitive merger agreement whereby Lilly will acquire Alnara, a privately held biotechnology company developing protein therapeutics for the treatment of metabolic diseases.

Original Source of Lilly to Acquire Alnara Pharmaceuticals

Welcome to to our annual look at the biggst CEO

Teva Pharmaceutical Industries has outgrown its simplistic corporate structure, so it’s creating a new one. Rather than operating through just two geographical divisions–the U.S. and everyplace else, i.e. Teva International Group–the company will now field four regional units to cover the globe. The restructuring abolishes Teva International, which had…